advertisement

---

Zhang N 8

Showing records 1 to 8 | Display all abstracts from Zhang N

95209 Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review
Zhang N
Scientific reports 2021; 11: 13762

---

95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Zhang X
Pharmaceutics 2021; 13:

---

95209 Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review
Wang J
Scientific reports 2021; 11: 13762

---

95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Zhang N; Chrenek MA
Pharmaceutics 2021; 13:

---

95209 Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review
Li Y
Scientific reports 2021; 11: 13762

---

95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Girardot PE
Pharmaceutics 2021; 13:

---

95209 Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review
Jiang B
Scientific reports 2021; 11: 13762

---

95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Wang J; Sellers JT; Geisert EE; Brenner C; Nickerson JM; Boatright JH; Li Y
Pharmaceutics 2021; 13:

---